Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
about
Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidenceMechanisms of epigenetic regulation of leukemia onset and progressionLifestyle Modifications and Colorectal CancerCancer prevention with promising natural products: mechanisms of action and molecular targetsPlasma proteins interaction with curcumin nanoparticles: implications in cancer therapeuticsThe circadian clock modulates anti-cancer properties of curcumin.Unraveling the Anticancer Effect of Curcumin and ResveratrolDietary polyphenols in prevention and treatment of prostate cancerHypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatmentpTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1)Lasiodin inhibits proliferation of human nasopharyngeal carcinoma cells by simultaneous modulation of the Apaf-1/caspase, AKT/MAPK and COX-2/NF-κB signaling pathwaysDiamond Nanoparticles Modify Curcumin Activity: In Vitro Studies on Cancer and Normal Cells and In Ovo Studies on Chicken Embryo ModelPIAS3 expression in squamous cell lung cancer is low and predicts overall survival.Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivoBladder cancer and urothelial impairment: the role of TRPV1 as potential drug target.Glo1 inhibitors for neuropsychiatric and anti-epileptic drug developmentUse of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells.Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis.Knockdown of Ki-67 by dicer-substrate small interfering RNA sensitizes bladder cancer cells to curcumin-induced tumor inhibition.Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese dyslipidemic subjects: A randomized double-blind placebo-controlled cross-over trial.Enhanced apoptotic effects by the combination of curcumin and methylseleninic acid: potential role of Mcl-1 and FAK.General aspects of colorectal cancerIdentifying molecular targets of lifestyle modifications in colon cancer prevention.Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial.Molecular mechanism of TGF-β signaling pathway in colon carcinogenesis and status of curcumin as chemopreventive strategy.The multifaceted role of curcumin in cancer prevention and treatment.Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.Curcumin acts anti-proliferative and pro-apoptotic in human meningiomas.Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in micePotential application of curcumin and its analogues in the treatment strategy of patients with primary epithelial ovarian cancer.Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells.Design, synthesis and experimental validation of novel potential chemopreventive agents using random forest and support vector machine binary classifiers.Advances in the research and development of natural health products as main stream cancer therapeuticsCurcumin inhibits leptin gene expression and secretion in breast cancer cells by estrogen receptors.A proteomic analysis of Curcuma comosa Roxb. rhizomes.3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesisHonokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects.Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: a comparative studyCurcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.
P2860
Q26745552-14E1DAEA-3758-4E11-937B-1C3C23D085BDQ26861785-6277EC2F-6376-4357-ACA1-49AE31E6A660Q26865414-264B47A2-5E1E-4BCD-8540-E0BBFE2763E5Q27006530-7D65DADF-6331-432A-9B6A-B6E8328FCFE0Q27026623-668E9713-B527-449F-8DAF-812D14C3C6F7Q27311369-8C9CF5BD-7F8D-4788-9BEB-C16BFB92D0C6Q28073155-F9A453CE-61EA-4E9F-904F-66558281765AQ28084787-E224A11A-0F39-4FA4-B1E7-9ED349A974F5Q28484357-C73C814E-C1EA-4A9C-B343-1FAC78796ADFQ28538995-ECCDAC07-418D-4FD0-A4A2-76638DD68BE8Q28539006-6B4C0CDC-9F55-47F7-A02B-18991B789C94Q28554730-386C173E-7FA8-423A-8AE6-8B81B4B2C2D1Q30405870-F9FFDF41-93BB-4BF9-85CF-78D0CBF0D655Q33598526-66EFA728-12FF-44AF-9B1F-68AEE089DC06Q33667193-52AFC16E-E0DB-4261-B990-F07B9EF0AC94Q33676132-8E3C5A67-8A67-44B8-B724-BF0CAA9469FAQ33827813-E09D77E7-26BB-4D57-998B-2BEE89221ECBQ33828424-74612639-ACE9-47D2-96D8-6BA16E59A1A0Q34362340-94035EFD-20DF-421A-99F2-A8142E38654EQ34477376-8816BB7C-BA3B-4F03-92A8-7A5F0C5952D8Q34609150-DC95159B-4E5B-4A31-AE22-0CF2DAE57C28Q34639407-1AEB27CC-AA52-4FCB-AC9D-470E95D54043Q34645999-EF53A770-156B-47F0-B359-74D38B3ACCE8Q34651881-A917B3F3-8DF2-4692-AB13-8ECB9B6D9C03Q34660475-447476E2-35CD-421F-A5C9-54A39E334A14Q34660663-203859B3-F0E8-41E3-A3C7-86FAC7C1B6A0Q34667865-7FBB997D-BAE1-454B-88F0-E34AB3625E9FQ34668705-724C6629-CCF0-4F01-A6FB-736A56DB27D5Q34716061-5A2625DB-47AF-4381-A53E-C8AB28B28755Q34794683-FB5F8B68-1179-49D7-9F01-44A19ED39861Q34833628-0337E9A4-84BB-4E84-A215-5E709C2FA039Q35013544-8011A486-CF0D-4A59-A467-5A2B86EC87A0Q35170923-72CB9A41-B689-47C1-ACC0-C0A8B180435FQ35344031-45EF10A8-B2DC-4191-A914-D66DAA176C08Q35358652-C4F443C9-4A45-4667-BB0D-AC0A660BDF70Q35426469-608E48E2-D91C-4288-B400-DC87D4A901ADQ35541678-253F41F3-F576-4358-87B0-13354DB5E9D1Q35562099-F6590423-E5FB-4927-9782-5B1BAE46DF86Q35679162-A2D5572D-391D-4D2F-87A8-30678E394B5EQ35692600-EC7A1D59-F599-4206-8765-00E937A8C894
P2860
Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@ast
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@en
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@nl
type
label
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@ast
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@en
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@nl
prefLabel
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@ast
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@en
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@nl
P2093
P2860
P356
P1476
Curcumin in cancer chemopreven ...... lability, and clinical trials.
@en
P2093
Adeeb Shehzad
Fazli Wahid
Young Sup Lee
P2860
P304
P356
10.1002/ARDP.200900319
P577
2010-09-01T00:00:00Z